Nurse Practitioner · Fishers, IN
NPI
1891445185
Since 2022
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
14300 E 138th Ste A
Fishers, IN, 46037
Phone (317) 813-1660
Groups this clinician bills Medicare through
Medicare paid, 2024
$77K
1,875 services
Medicare patients, 2024
509
Average age 76
Drug cost, 2024
$802K
1,702 prescriptions
Company payments, 2025
$327
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Julie K Dorsett was code 99214 (office e&m - established), 292 times for 212 patients. In total Julie K Dorsett billed 1,875 services in 36 codes, and Medicare paid $77K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 292 | 212 | $73.47 | $21K |
| 99213 Office E&M - Established | Office | 251 | 202 | $49.61 | $12K |
| 51798 Ultrasound - Nonspecific | Office | 243 | 219 | $7.25 | $1,762 |
| 99459 Office/Outpatient Services | Office | 176 | 109 | $12.55 | $2,209 |
| 81003 Clinical Chemistry | Office | 172 | 156 | $2.20 | $378 |
| 64566 Musculoskeletal | Office | 98 | 15 | $68.17 | $6,680 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 81 | 71 | $10.14 | $821 |
| 81001 Clinical Chemistry | Office | 80 | 72 | $3.11 | $249 |
| 99204 Office E&M - New | Office | 74 | 74 | $94.41 | $6,986 |
| A4562 Pessary, reusable, non rubber, any type | Office | 58 | 43 | $51.56 | $2,990 |
| 99212 Office E&M - Established | Office | 54 | 42 | $32.72 | $1,767 |
| 57160 Other Organ Systems | Office | 44 | 36 | $40.84 | $1,797 |
| 51797 Other Organ Systems | Office | 37 | 37 | $116.21 | $4,300 |
| 51741 Test - Miscellaneous | Office | 37 | 37 | $4.39 | $162 |
| 51728 Other Organ Systems | Office | 37 | 37 | $214.14 | $7,923 |
By year: 2022 $36K for 666 services; 2023 $82K for 1,678 services; 2024 $77K for 1,875 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 172 | 156 | $2.20 | $378 |
| 81001 Clinical Chemistry | 80 | 72 | $3.11 | $249 |
Medicare prescription drug claims, 2024
In 2024, the drug Julie K Dorsett prescribed most often to Medicare patients was Gemtesa (Vibegron), with 633 prescriptions and refills. In total Julie K Dorsett wrote 1,702 Medicare prescriptions that cost $802K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gemtesa Vibegron | 633 | 1,130 | 174 | $532K |
| Myrbetriq Mirabegron | 311 | 480 | 89 | $214K |
| Estradiol Generic | 249 | 619 | 128 | $18K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 123 | 123 | 87 | $1,101 |
| Cephalexin Generic | 79 | 126 | 40 | $756 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 67 | 94 | 22 | $1,765 |
| Trospium Chloride Generic | 46 | 56 | 14 | $2,536 |
| Trimethoprim Generic | 32 | 38 | Under 11 | $1,171 |
| Mirabegron Er Mirabegron | 29 | 51 | 14 | $16K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 22 | 22 | 18 | $45.17 |
| Yuvafem Estradiol | 15 | 21 | Under 11 | $2,764 |
| Ciprofloxacin Hcl Generic | 13 | 13 | 13 | $33.74 |
| Estring Estradiol | 12 | 36 | Under 11 | $6,825 |
Brand drugs: 1,005 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Julie K Dorsett $327 ($327 in general payments such as food, travel and fees) from 6 companies. The largest payer was Sumitomo Pharma America, Inc. with $116.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.